Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple endogenous mRNAs with miR-216a seed matches refers to the collective ensemble of messenger RNA (mRNA) transcripts that are post-transcriptionally regulated by microRNA-216a (miR-216a). miR-216a is a highly conserved, pancreas-specific microRNA that plays a critical role in maintaining cellular homeostasis and modulating signaling pathways by binding to complementary seed sequences in the 3' untranslated regions (UTRs) of target mRNAs (PubMed: 21835060). This binding typically results in the degradation of the mRNA or the inhibition of its translation into protein via the RNA-induced silencing complex (RISC). Key validated targets within this group include PTEN, which regulates the PI3K/Akt pathway, and SMAD7, a negative regulator of TGF-beta signaling (PubMed: 25135801, PubMed: 24631445). In diseases such as pancreatic cancer, miR-216a often acts as a tumor suppressor by targeting oncogenes like YBX1, whereas in kidney disease, its upregulation can contribute to fibrosis by silencing protective factors. Therapeutic strategies involve using miR-216a mimics to restore its suppressive function in cancer or antagomirs to block its activity in fibrotic conditions. Consequently, this target represents a complex regulatory network rather than a single molecular entity.
MicroRNA-mediated gene silencing via seed-sequence complementarity to the 3' UTR of target mRNAs, leading to mRNA cleavage or translational inhibition.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple endogenous mRNAs with miR-216a seed matches.